Against Mandating COVID-19 Booster Shots for Children Under 18
This paper argues that the United States should not mandate COVID-19 booster shots for children aged 18 years and younger. Drawing on epidemiological data, comparative international policy, ethical frameworks including principlism and public health principles, and statements from leading health experts, the paper contends that healthy, fully vaccinated children are already well protected by two doses, that the available data does not support the added benefit of boosters for this population, and that the risk of adverse effects such as myocarditis outweighs any marginal gain. The paper also presents and rebuts the counterargument that boosters protect immunocompromised individuals by achieving herd immunity, concluding that resources would be better directed toward vaccinating unvaccinated, high-risk populations.
- Introduction: Thesis statement against mandating boosters for children
- Background: COVID-19 Risk in Children and Comparative Policy: Low pediatric risk and international policy comparison
- Claim 1: Boosters Are Not Needed for Healthy, Fully Vaccinated Children: Two doses provide sufficient protection; ethical analysis
- Claim 2: The Data Does Not Support Boosters for Children: Empirical evidence against boosters for this age group
- Expert Opposition and Public Health Principles: Expert quotes and public health ethics framework
- Counterargument and Rebuttal: Herd immunity argument presented and refuted
- Conclusion: Summary of claims and restatement of thesis
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- The paper structures its argument systematically — presenting two independent affirmative claims, a counterargument, and a formal rebuttal — which creates a rigorous, debate-style logical progression.
- It integrates multiple ethical frameworks (beneficence, nonmaleficence, autonomy, justice, solidarity, efficacy) alongside empirical data, demonstrating interdisciplinary reasoning rather than relying solely on statistics or solely on philosophy.
- Direct quotations from credentialed authorities (WHO Chief Scientist, CDC Director, FDA advisory members) are used strategically to reinforce claims and lend institutional weight to the argument.
Key academic technique demonstrated
The paper demonstrates claim-counterclaim-rebuttal structure, a core technique in policy argumentation. By presenting the opposing view charitably — including its utilitarian philosophical grounding in Parfit's Principle of Group Beneficence — and then rebutting it with specific legal precedent (Jacobson v. Massachusetts) and real-world transmission data, the paper models how to engage opposing arguments rather than ignore them, strengthening overall persuasiveness.
Structure breakdown
The paper opens with an introduction stating its thesis, followed by a background section contextualizing COVID-19 risk in children and comparing international booster policies. Two affirmative claims are then developed — one grounded in medical necessity, one in empirical data — each supported by ethical frameworks. A section compiling expert opposition follows, after which the counterargument is presented and rebutted. The conclusion summarizes all supporting points and restates the thesis.
Introduction
The desire to develop and execute a vaccine to prevent infection with coronavirus disease 2019 (COVID-19) has been extraordinary. With the vaccine developed, the US government has put in place vaccine mandates to increase uptake among those who are eligible. However, the continued mutation of the virus has brought about the need for vaccine boosters to improve immunity across the population (Gostin, Salmon & Larson, 2021; World Health Organization [WHO], 2020). Intending to achieve herd immunity, health experts have also recommended the vaccination of children. Even though children are not at risk of being severely infected by COVID-19, they can still carry the disease. This has, however, raised the question of whether children aged 18 years and younger should be subject to a COVID-19 vaccine booster mandate.
This paper argues that the United States should not mandate COVID-19 booster shots for children 18 and younger. The discussion proceeds by presenting arguments supporting this proposition, presenting a claim against it, offering a rebuttal, and then concluding.
Background: COVID-19 Risk in Children and Comparative Policy
The US Food and Drug Administration (FDA) granted emergency use authorization for the BNT162b2 (Pfizer-BioNTech) COVID-19 vaccine in children aged 5 to 11 years in October 2021 to reduce expensive hospitalizations. By that time, 1.8 million children in this age range had been diagnosed with SARS-CoV-2 infection, with 143 deaths and over 8,000 hospitalizations (Encinosa, Figueroa & Elias, 2022). By contrast, for the 2019–2020 influenza season, an estimated 35 million flu-related illnesses, 16 million flu-related medical visits, 380,000 flu-related hospitalizations, and 20,000 flu-related deaths were reported (CDC, 2021). Based on these figures, it is evident that influenza has a higher mortality rate among children, yet the flu shot is not mandatory.
COVID-19 has been reported in fewer young people than in adults in the United States and worldwide. Although children make up around 22% of the US population, they accounted for more than 17% of all COVID-19 cases reported to the Centers for Disease Control and Prevention (CDC) as of December 23, 2021 (CDC, 2022a). Most cases in children are mild, and supportive care is the most common treatment. In the debate over whether to institute booster mandates for children aged 18 and below, influenza offers useful comparative perspective. Both influenza and COVID-19 are contagious respiratory illnesses that affect the lungs and breathing and can be transmitted to others. COVID-19, however, appears to follow a milder clinical and laboratory course in children (Yılmaz et al., 2021).
Children without a serious medical condition have a very low risk of developing severe COVID-19 or long COVID. It is difficult to precisely measure that risk because it is so low, and it applies to both vaccinated and unvaccinated children (University College London, 2021). The reported number of COVID-19 hospitalizations for children in California — one of the major measures for assessing epidemic severity — was found to be dramatically overstated (Zweig, 2021a). This overstatement has distorted public perception of COVID-19's danger to children.
Compared to other countries' approaches to COVID-19 vaccination, the United States stands out as an exception, maintaining the strictest vaccination program for young people. Japan, Finland, Denmark, Norway, and several other countries have taken a more cautious approach to vaccines and boosters for children (Zweig, 2021b). Adult boosters are only required in Denmark, Sweden, and Japan. Some countries do not recommend COVID-19 vaccinations for healthy infants at all, or administer only one dose. A single dose is available for children aged 5 to 11, while a second dose is available for children aged 12 to 15. In Ireland, no one under the age of 16 is eligible for booster shots. In the United Kingdom, boosters are permitted only for teenagers aged 12 to 15 who are at very high risk.
Finally, according to the WHO, despite advances in vaccine production and research, the COVID-19 virus is likely to persist and circulate through society in a manner similar to influenza. This is significant because the Delta variant — a mutation of the original COVID-19 strain — was responsible for the bulk of new cases in the United States in mid and late 2021 (Kelley, 2021). Clinical evidence also shows that the protection provided by the Pfizer, Moderna, and Johnson & Johnson vaccines diminishes over time, which has been used to justify booster shots to prevent new infections.
Claim 1: Boosters Are Not Needed for Healthy, Fully Vaccinated Children
Children who have received two doses of a COVID-19 vaccine are well protected. Those who have been fully vaccinated are protected from serious illness, hospitalization, and death (Bajema et al., 2021). COVID-19 vaccines — particularly those manufactured by Pfizer-BioNTech and Moderna — have been effective in preventing COVID-19-related hospitalizations. As late as January 2022, the WHO maintained that there was no evidence that healthy children and adolescents required COVID-19 vaccination booster doses (Bursztynsky, 2022).
Major Israeli population research (Bar-On et al., 2021) indicated that two vaccine doses carried no risk of COVID mortality in those under 30. Understanding the booster dose's protective effect in younger age groups is critical for developing sound public health policy. The study by Bar-On et al. (2021) provides evidence for the short-term effectiveness of the booster dose against the once-dominant Delta variant in persons 16 years of age and older. However, booster vaccination programs may only provide a way to control transmission without costly social-distancing measures and quarantines, while not offering significant additional protection for healthy, fully vaccinated children.
From a beneficence standpoint, a booster dose provides no additional benefit to healthy, fully vaccinated children, and there is no medical value in boosting healthy young people. Children have a low-risk profile in general and are not considered a vulnerable or high-risk population. Fully vaccinated healthy children already have long-term protection from severe illness, hospitalization, and death from two doses alone. Children who have had two doses plus an Omicron infection have even better immunity than those who have had two doses alone — notably, the Omicron variant appears to function as a form of natural vaccination, stimulating B and T cell immunity (Callaway, 2022; Krause, Offit & Borio, 2022). Health experts have likewise concluded that a booster shot for healthy adolescents would not be necessary (Howard, 2021).
From a nonmaleficence perspective, a third shot may do more harm than good for healthy young people (Makary, 2021). Booster doses intended to produce only temporary reductions in mild and asymptomatic infections risk causing medical harm. In a study by Mevorach et al. (2021), 56 out of 438,511 boys aged 16 to 24 developed myocarditis following their second Pfizer dose — approximately 1 in 7,830, at least seven times the baseline rate. Although most cases were mild, seven of the 136 individuals who developed myocarditis after vaccination experienced a "difficult course," and one 22-year-old died. Moderna's vaccine carries an even higher risk of cardiac complications, which is why it is unavailable to those under age 30 in some European countries. According to data presented at the CDC advisory committee meeting where members voted to suggest boosters for 12- to 17-year-olds, males in this age group face a negative cost-benefit ratio: a fully vaccinated male aged 12 to 17 has a 0.3 in 100,000 chance of COVID-19-related hospitalization, but if boosted, a 10 in 100,000 chance of myocarditis (CDC, 2022b).
Considering boosters for children also requires attention to autonomy. Under American law, children are not fully autonomous individuals unless they are emancipated, married, 18 years old, or have a child of their own. Decisions about booster shots should remain with parents, who must weigh whether it is worthwhile to boost their healthy, fully vaccinated child with a shot that is only effective for approximately 2 to 4 months and carries the potential for harm — particularly in male children — for a disease that typically does not seriously affect them.
Finally, there is no justice in mandating COVID-19 booster shots for children. Given the significant risk COVID-19 poses to adults — particularly those with underlying conditions — and the large number of unvaccinated populations worldwide, it is inequitable to mandate boosters for children. Healthy, fully vaccinated young people are already well protected, and these resources would be better directed to high-risk and vulnerable populations who need additional protection. As Krause, Gruber, and Offit (2021) argue, vaccinating the unvaccinated — wherever they live — is the only way to defeat the coronavirus. Even in wealthier countries, the focus on boosting may hinder that effort and prevent people in lower-income countries from accessing first doses. Those who remain unvaccinated are not all unreachable. Booster doses being considered for healthy children would almost certainly do considerably more good if used to immunize unvaccinated, vulnerable persons, whether in the United States or abroad.
Conclusion
With the US government seeking to use all available tools to curb the spread of COVID-19 and reduce related hospitalizations, vaccine mandates represent one option. This paper has argued against mandating COVID-19 booster shots for children aged 18 years and below. In support of this position, the paper has presented the following key points:
Children have a low-risk profile for COVID-19, which applies to both vaccinated and unvaccinated children. Children who have been fully vaccinated are protected from serious disease and death. Boosters are not medically required or necessary for fully vaccinated, healthy children. The available data does not support boosters for healthy, fully vaccinated young people. Encouragement and persuasion are the most effective public health methods. The best course of action is to encourage unvaccinated individuals to receive their initial doses while directing supplementary injections to those who will benefit most — such as the elderly and those with compromised immune systems. Coercive policies, such as requiring medical treatment as a condition of employment or education, must be supported by robust evidence. A mandatory booster for healthy children does not meet that standard.
Based on these points, the conclusion is that the United States should not mandate COVID-19 booster shots for children 18 and younger.
Alexander, H. (2022, February 22). CDC is refusing to publish data it has collected on booster effectiveness for 33 million Americans aged 18–49 over fears it might show the vaccines as ineffective: FDA expert tells CDC to 'tell the truth.' Daily Mail. Retrieved from https://www.dailymail.co.uk/news/article-10537161/CDC-refusing-publish-data-collected-booster-effectiveness-aged-18-49.html
Ali, S. (2022, January 12). Alarmingly low number of children are fully vaccinated in the US. Changing America. Retrieved from
Bajema, K. L., Dahl, R. M., Prill, M. M., Meites, E., Rodriguez-Barradas, M. C., Marconi, V. C., ... & for Enteric, S. P. (2021). Effectiveness of COVID-19 mRNA vaccines against COVID-19–associated hospitalization — Five Veterans Affairs Medical Centers, United States, February 1–August 6, 2021. Morbidity and Mortality Weekly Report, 70(37), 1294.
Bar-On, Y. M., Goldberg, Y., Mandel, M., Bodenheimer, O., Freedman, L., Alroy-Preis, S., ... & Milo, R. (2021). Protection against Covid-19 by BNT162b2 booster across age groups. New England Journal of Medicine, 385(26), 2421–2430.
Bhatt, J. (2021, November 4). Got your booster? Here are 5 reasons to keep following public health measures for a bit longer. ABC News. Retrieved from https://abcnews.go.com/US/booster-reasons-public-health-measures-bit-longer/story?id=80908775
Bursztynsky, J. (2022, January 18). WHO says there's no evidence healthy children and adolescents need Covid boosters. CNBC. Retrieved from https://www.cnbc.com/2022/01/18/who-says-theres-no-evidence-healthy-children-adolescents-need-covid-boosters.html
Callaway, E. (2022). Breakthrough COVID powers up immune response to variants — including Omicron. Nature. Retrieved from https://www.nature.com/articles/d41586-022-00328-8
CDC. (2021). Estimated flu-related illnesses, medical visits, hospitalizations, and deaths in the United States — 2019–2020 flu season. Retrieved from https://www.cdc.gov/flu/about/burden/2019-2020.html
CDC. (2022a). Demographic trends of COVID-19 cases and deaths in the US reported to CDC. Retrieved from https://covid.cdc.gov/covid-data-tracker/#demographics
CDC. (2022b). January 5, 2022 ACIP meeting — Welcome & Coronavirus Disease 2019 (COVID-19) vaccines [Video]. YouTube. Retrieved from https://www.youtube.com/watch?v=Nmiud-Cw53s&t=2257s
Encinosa, W., Figueroa, J., & Elias, Y. (2022). Severity of hospitalizations from SARS-CoV-2 vs. influenza and respiratory syncytial virus infection in children aged 5 to 11 years in 11 US states. JAMA Pediatrics.
Ferdinands, J. M., Rao, S., Dixon, B. E., Mitchell, P. K., DeSilva, M. B., Irving, S. A., ... & Fireman, B. (2022). Waning 2-dose and 3-dose effectiveness of mRNA vaccines against COVID-19–associated emergency department and urgent care encounters and hospitalizations among adults during periods of Delta and Omicron variant predominance — VISION Network, 10 states, August 2021–January 2022.
Giubilini, A., Douglas, T., & Savulescu, J. (2018). The moral obligation to be vaccinated: Utilitarianism, contractualism, and collective easy rescue. Medicine, Health Care and Philosophy, 21(4), 547–560.
Goel, R. R., Painter, M. M., Apostolidis, S. A., Mathew, D., Meng, W., Rosenfeld, A. M., ... & Wherry, E. J. (2021). mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern. Science, 374(6572), abm0829.
Gostin, L. O., Salmon, D. A., & Larson, H. J. (2021). Mandating COVID-19 vaccines. JAMA, 325(6), 532–533.
Grannis, S. J., Rowley, E. A., Ong, T. C., Stenehjem, E., Klein, N. P., DeSilva, M. B., ... & VISION Network. (2021). Interim estimates of COVID-19 vaccine effectiveness against COVID-19–associated emergency department or urgent care clinic encounters and hospitalizations among adults during SARS-CoV-2 B.1.617.2 (Delta) variant predominance — Nine states, June–August 2021. Morbidity and Mortality Weekly Report, 70(37), 1291.
Howard, J. (2021, November 25). Children and teens are less likely to need Covid-19 boosters, Fauci says. Here's why. CNN. Retrieved from https://edition.cnn.com/2021/11/25/health/covid-booster-adolescents-fauci-wellness/index.html
Kelley, A. (2021, September 7). COVID-19 won't be eradicated: WHO. Changing America. Retrieved from
Krause, P. R., Fleming, T. R., Peto, R., Longini, I. M., Figueroa, J. P., Sterne, J. A., ... & Henao-Restrepo, A. M. (2021). Considerations in boosting COVID-19 vaccine immune responses. The Lancet, 398(10308), 1377–1380.
Krause, P., Gruber, M. F., & Offit, P. A. (2021, November 29). We don't need universal booster shots. We need to reach the unvaccinated. The Washington Post. Retrieved from https://www.washingtonpost.com/outlook/2021/11/29/booster-shots-universal-opinion/
Krause, P., Offit, P. A., & Borio, L. (2022, February 10). People who have had Covid-19 don't need three vaccine shots. The Washington Post. Retrieved from https://www.washingtonpost.com/outlook/2022/02/10/infection-vaccination-protection-mandates-cdc/
Kuhlmann, C., Mayer, C. K., Claassen, M., Maponga, T., Burgers, W. A., Keeton, R., ... & Preiser, W. (2022). Breakthrough infections with SARS-CoV-2 Omicron despite mRNA vaccine booster dose. The Lancet.
Makary, M. (2021, December 21). The dangerous push to give boosters to teens. The Wall Street Journal. Retrieved from https://www.wsj.com/articles/dangerous-push-to-give-boosters-to-teens-vacccine-covid-19-omicron-vaxx-requirement-mandate-11640107759
Mevorach, D., Anis, E., Cedar, N., Bromberg, M., Haas, E. J., Nadir, E., ... & Alroy-Preis, S. (2021). Myocarditis after BNT162b2 mRNA vaccine against Covid-19 in Israel. New England Journal of Medicine, 385(23), 2140–2149.
Montagnier, L., & Rubenfeld, J. (2022, January 9). Omicron makes Biden's vaccine mandates obsolete. Wall Street Journal.
Reuters. (2022, January 19). WHO says no evidence healthy children, adolescents need COVID-19 boosters. Retrieved from https://www.reuters.com/business/healthcare-pharmaceuticals/who-says-no-evidence-healthy-children-adolecents-need-covid-19-boosters-2022-01-18/
Rosenberg, E. S., Dorabawila, V., Easton, D., Bauer, U. E., Kumar, J., Hoen, R., ... & Zucker, H. A. (2021). COVID-19 vaccine effectiveness by product and timing in New York state. medRxiv.
Sguazzim, A., & Bloomberg. (2022). COVID boosters do not provide protection against Omicron, study finds. Fortune. Retrieved from https://fortune.com/2022/01/19/covid-19-boosters-block-immunity-omicron-study-finds/
Stieg, C. (2021). There's a major thing people are missing about Covid boosters — and it's really important. CNBC. Retrieved from https://www.cnbc.com/2021/09/16/booster-debate-covid-vaccine-not-meant-to-prevent-infection-symptoms.html
UK Health Security Agency. (2021). SARS-CoV-2 variants of concern and variants under investigation in England. Retrieved from https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1043807/technical-briefing-33.pdf
University College London. (2021). Covid-19: Risks of severe illness in children shown to be very low. Retrieved from https://www.ucl.ac.uk/news/2021/jul/covid-19-risks-severe-illness-children-shown-be-very-low
Walsh, J. (2021, December 15). A skeptic's case against boosting everyone. Intelligencer. Retrieved from https://nymag.com/intelligencer/2021/12/omicron-dr-paul-offit-is-skeptical-of-boosters-for-all.html
Watson, C. (2022, January 28). Three, four, or more: what's the magic number for booster shots? Nature. Retrieved from https://www.nature.com/articles/d41586-022-00200-9
World Health Organization. (2020, August 28). WHO's Science in 5 on COVID-19 — Herd immunity [Video]. YouTube. Retrieved from https://www.youtube.com/watch?v=U47SaDAmyrE
World Health Organization. (2021). COVID-19 and mandatory vaccination: Ethical considerations and caveats: Policy brief, April 13, 2021.
Yılmaz, K., Şen, V., Aktar, F., Onder, C., Yılmaz, E. D., & Yılmaz, Z. (2021). Does Covid-19 in children have a milder course than influenza? International Journal of Clinical Practice, 75(9), e14466.
Zweig, D. (2021a). New research suggests number of kids hospitalized for COVID is overcounted. Intelligencer. Retrieved from https://nymag.com/intelligencer/2021/05/study-number-of-kids-hospitalized-for-covid-is-overcounted.html
Zweig, D. (2021b). Why are we boosting kids? Common Sense. Retrieved from https://bariweiss.substack.com/p/why-are-we-boosting-kids
Always verify citation format against your institution’s current style guide requirements.